UNLABELLED: Effect of milk basic protein on bone metabolism in healthy young women. INTRODUCTION: Milk has more beneficial effects on bone health than other food sources. Recent in vitro and in vivo studies have shown that milk whey protein, especially its basic protein fraction (milk basic protein, MBP), contains several components capable of promoting bone formation and inhibiting bone resorption. The object of this study was to examine the effect of MBP on the bone mineral density and bone metabolism of healthy young women. METHODS:Thirty-five healthy young women were randomly assigned to treatment with either placebo or MBP (40 mg per day) for 6 months. The bone mineral density (BMD) of the lumbar vertebrae L2-L4 of each subject was measured by dual-energy X-ray absorptiometry (DXA) at 0 and 6 months of treatment. Serum and urine indexes of bone metabolism were measured at 0, 3 and 6 months. All subjects completed the study in accordance with the protocol. RESULTS: The mean rate of gain of lumbar BMD in the MBP group (1.57%) was significantly higher than in the placebo group (0.13%, P=0.042). When compared with the placebo group, urinary cross-linked N-telopeptides of type-I collagen (NTx) were significantly decreased, and serum osteocalcin was significantly increased in the MBP group at 6 months. CONCLUSION: These results suggested that MBP supplementation was effective in increasing BMD in young women and that this increase in BMD may be primarily mediated through the promotion of bone formation and inhibition of bone resorption by MBP supplementation.
RCT Entities:
UNLABELLED: Effect of milk basic protein on bone metabolism in healthy young women. INTRODUCTION: Milk has more beneficial effects on bone health than other food sources. Recent in vitro and in vivo studies have shown that milk whey protein, especially its basic protein fraction (milk basic protein, MBP), contains several components capable of promoting bone formation and inhibiting bone resorption. The object of this study was to examine the effect of MBP on the bone mineral density and bone metabolism of healthy young women. METHODS: Thirty-five healthy young women were randomly assigned to treatment with either placebo or MBP (40 mg per day) for 6 months. The bone mineral density (BMD) of the lumbar vertebrae L2-L4 of each subject was measured by dual-energy X-ray absorptiometry (DXA) at 0 and 6 months of treatment. Serum and urine indexes of bone metabolism were measured at 0, 3 and 6 months. All subjects completed the study in accordance with the protocol. RESULTS: The mean rate of gain of lumbar BMD in the MBP group (1.57%) was significantly higher than in the placebo group (0.13%, P=0.042). When compared with the placebo group, urinary cross-linked N-telopeptides of type-I collagen (NTx) were significantly decreased, and serum osteocalcin was significantly increased in the MBP group at 6 months. CONCLUSION: These results suggested that MBP supplementation was effective in increasing BMD in young women and that this increase in BMD may be primarily mediated through the promotion of bone formation and inhibition of bone resorption by MBP supplementation.
Authors: Y Toba; Y Takada; Y Matsuoka; Y Morita; M Motouri; T Hirai; T Suguri; S Aoe; H Kawakami; M Kumegawa; A Takeuchi; A Itabashi Journal: Biosci Biotechnol Biochem Date: 2001-06 Impact factor: 2.043
Authors: S Aoe; Y Toba; J Yamamura; H Kawakami; M Yahiro; M Kumegawa; A Itabashi; Y Takada Journal: Biosci Biotechnol Biochem Date: 2001-04 Impact factor: 2.043
Authors: Niels Peter Möller; Katharina Elisabeth Scholz-Ahrens; Nils Roos; Jürgen Schrezenmeir Journal: Eur J Nutr Date: 2008-05-27 Impact factor: 5.614
Authors: Y Sato; M Iki; Y Fujita; J Tamaki; K Kouda; A Yura; J-S Moon; R Winzenrieth; H Iwaki; R Ishizuka; N Amano; K Tomioka; N Okamoto; N Kurumatani Journal: Osteoporos Int Date: 2015-01-28 Impact factor: 4.507
Authors: Jeannette M Beasley; Laura E Ichikawa; Brett A Ange; Leslie Spangler; Andrea Z LaCroix; Susan M Ott; Delia Scholes Journal: Am J Clin Nutr Date: 2010-03-10 Impact factor: 7.045
Authors: L Esterle; J-P Sabatier; F Guillon-Metz; O Walrant-Debray; G Guaydier-Souquières; F Jehan; M Garabédian Journal: Osteoporos Int Date: 2008-08-14 Impact factor: 4.507
Authors: R Rizzoli; E Biver; J-P Bonjour; V Coxam; D Goltzman; J A Kanis; J Lappe; L Rejnmark; S Sahni; C Weaver; H Weiler; J-Y Reginster Journal: Osteoporos Int Date: 2018-05-08 Impact factor: 4.507